1
|
Weng L, Zhao M, Zhang Y, Liu X, Wang Z, Xu R, Zhang J, Wang Y, Wang M, Zhao C. American ginseng vesicles loaded hyaluronic acid hydrogel for ulcerative colitis. Int J Biol Macromol 2025; 288:138565. [PMID: 39662541 DOI: 10.1016/j.ijbiomac.2024.138565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2024] [Revised: 12/01/2024] [Accepted: 12/06/2024] [Indexed: 12/13/2024]
Abstract
The present study introduces a novel therapeutic approach for ulcerative colitis (UC) utilizing American ginseng vesicles encapsulated within a hyaluronic acid (HA) hydrogel matrix. UC, a prevalent form of inflammatory bowel disease, is characterized by chronic inflammation of the colonic mucosa, leading to significant morbidity and compromised quality of life. Existing therapeutic modalities such as 5-Aminosalicylic acid (5-ASA) are associated with substantial side effects and a high recurrence rate. Thus, there is an unmet need for alternative treatments that offer enhanced efficacy with reduced adverse effects. Leveraging the anti-inflammatory properties of American ginseng vesicles HA -hydrogels of HA hydrogel (5-ASA + ANPs@HA), this study presents a targeted drug delivery system designed to provide localized therapy for UC. We synthesized the hydrogel matrix by HA and 1,4-butanediol diglycidyl ether (BDDE) at concentrations of 1 % NaOH and 0.8 %, v/v, respectively. The water content of the hydrogel was about 80 % to 90 %, and 82 % of Rb1 was released in 61 min. Our results demonstrate a significant reduction in disease symptoms, a substantial decrease in pro-inflammatory cytokines, and marked enhancement in mucosal healing following treatment with the 5-ASA + ANPs@HA. Collectively, these results suggest that the 5-ASA + ANPs@HA represents a promising therapeutic strategy for UC, warranting further investigation for clinical application.
Collapse
Affiliation(s)
- Ling Weng
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China Wenhua Road 103, Shenyang, Liaoning Province, China; Jiangsu Province Academy of Traditional Chinese Medicine, Hongshan Road 100, Jiangsu Province 210014, China
| | - Min Zhao
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China Wenhua Road 103, Shenyang, Liaoning Province, China
| | - Yumeng Zhang
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China Wenhua Road 103, Shenyang, Liaoning Province, China
| | - Xinyu Liu
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China Wenhua Road 103, Shenyang, Liaoning Province, China
| | - Zheyong Wang
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China Wenhua Road 103, Shenyang, Liaoning Province, China
| | - Ruixiang Xu
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China Wenhua Road 103, Shenyang, Liaoning Province, China
| | - Jiayi Zhang
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China Wenhua Road 103, Shenyang, Liaoning Province, China
| | - Yingjie Wang
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China Wenhua Road 103, Shenyang, Liaoning Province, China
| | - Miao Wang
- School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning Province, China
| | - Chunjie Zhao
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China Wenhua Road 103, Shenyang, Liaoning Province, China.
| |
Collapse
|
2
|
Tian L, Gao R, Cai Y, Chen J, Dong H, Chen S, Yang Z, Wang Y, Huang L, Xu Z. A systematic review of ginsenoside biosynthesis, spatiotemporal distribution, and response to biotic and abiotic factors in American ginseng. Food Funct 2024; 15:2343-2365. [PMID: 38323507 DOI: 10.1039/d3fo03434h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2024]
Abstract
American ginseng (Panax quinquefolius) has gained recognition as a medicinal and functional food homologous product with several pharmaceutical, nutritional, and industrial applications. However, the key regulators involved in ginsenoside biosynthesis, the spatiotemporal distribution characteristics of ginsenosides, and factors influencing ginsenosides are largely unknown, which make it challenging to enhance the quality and chemical extraction processes of the cultivated American ginseng. This review presents an overview of the pharmacological effects, biosynthesis and spatiotemporal distribution of ginsenosides, with emphasis on the impacts of biotic and abiotic factors on ginsenosides in American ginseng. Modern pharmacological studies have demonstrated that American ginseng has neuroprotective, cardioprotective, antitumor, antidiabetic, and anti-obesity effects. Additionally, most genes involved in the upregulation of ginsenoside biosynthesis have been identified, while downstream regulators (OSCs, CYP450, and UGTs) require further investigation. Futhermore, limited knowledge exists regarding the molecular mechanisms of the impact of biotic and abiotic factors on ginsenosides. Notably, the nonmedicinal parts of American ginseng, particularly its flowers, fibrous roots, and leaves, exhibit higher ginsenoside content than its main roots and account for a considerable amount of weight in the whole plant, representing promising resources for ginsenosides. Herein, the prospects of molecular breeding and metabolic engineering based on multi-omics to improve the unstable quality of cultivated American ginseng and the shortage of ginsenosides are proposed. This review highlights the gaps in the current research on American ginseng and proposes solutions to address these limitations, providing a guide for future investigations into American ginseng ginsenosides.
Collapse
Affiliation(s)
- Lixia Tian
- School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, China
| | - Ranran Gao
- The Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100007, China
| | - Yuxiang Cai
- School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, China
| | - Junxian Chen
- School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, China
| | - Hongmei Dong
- School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, China
| | - Shanshan Chen
- Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, 100700, China
| | - Zaichang Yang
- School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, China
| | - Yu Wang
- Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
| | - Linfang Huang
- Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
| | - Zhichao Xu
- College of Life Science, Northeast Forestry University, Harbin, 150006, China.
| |
Collapse
|
3
|
Ginsenosides in cancer: A focus on the regulation of cell metabolism. Biomed Pharmacother 2022; 156:113756. [DOI: 10.1016/j.biopha.2022.113756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2022] [Revised: 09/17/2022] [Accepted: 09/26/2022] [Indexed: 11/23/2022] Open
|
4
|
MIL-101 (Fe) @Ag Rapid Synergistic Antimicrobial and Biosafety Evaluation of Nanomaterials. Molecules 2022; 27:molecules27113497. [PMID: 35684436 PMCID: PMC9182184 DOI: 10.3390/molecules27113497] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Revised: 05/23/2022] [Accepted: 05/24/2022] [Indexed: 02/01/2023] Open
Abstract
Metal-organic frameworks (MOFs), which have become popular in recent years as excellent carriers of drugs and biomimetic materials, have provided new research ideas for fighting pathogenic bacterial infections. Although various antimicrobial metal ions can be added to MOFs with physical methods, such as impregnation, to inhibit bacterial multiplication, this is inefficient and has many problems, such as an uneven distribution of antimicrobial ions in the MOF and the need for the simultaneous addition of large doses of metal ions. Here, we report on the use of MIL-101(Fe)@Ag with efficient metal-ion release and strong antimicrobial efficiency for co-sterilization. Fe-based MIL-101(Fe) was synthesized, and then Ag+ was uniformly introduced into the MOF by the substitution of Ag+ for Fe3+. Scanning electron microscopy, powder X-ray diffraction (PXRD) Fourier transform infrared spectroscopy, and thermogravimetric analysis were used to investigate the synthesized MIL-101(Fe)@Ag. The characteristic peaks of MIL-101(Fe) and silver ions could be clearly seen in the PXRD pattern. Comparing the diffraction peaks of the simulated PXRD patterns clearly showed that MIL-101(Fe) was successfully constructed and silver ions were successfully loaded into MIL-101(Fe) to synthesize an MOF with a bimetallic structure, that is, the target product MIL-101(Fe)@Ag. The antibacterial mechanism of the MOF material was also investigated. MIL-101(Fe)@Ag exhibited low cytotoxicity, so it has potential applications in the biological field. Overall, MIL-101(Fe)@Ag is an easily fabricated structurally engineered nanocomposite with broad-spectrum bactericidal activity.
Collapse
|
5
|
Przeor M. Some Common Medicinal Plants with Antidiabetic Activity, Known and Available in Europe (A Mini-Review). Pharmaceuticals (Basel) 2022; 15:ph15010065. [PMID: 35056122 PMCID: PMC8778315 DOI: 10.3390/ph15010065] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Revised: 12/13/2021] [Accepted: 12/15/2021] [Indexed: 02/07/2023] Open
Abstract
Diabetes is a metabolic disease that affected 9.3% of adults worldwide in 2019. Its co-occurrence is suspected to increase mortality from COVID-19. The treatment of diabetes is mainly based on the long-term use of pharmacological agents, often expensive and causing unpleasant side effects. There is an alarming increase in the number of pharmaceuticals taken in Europe. The aim of this paper is to concisely collect information concerning the few antidiabetic or hypoglycaemic raw plant materials that are present in the consciousness of Europeans and relatively easily accessible to them on the market and sometimes even grown on European plantations. The following raw materials are discussed in this mini-review: Morus alba L., Cinnamomum zeylanicum J.Presl, Trigonella foenum-graecum L., Phaseolus vulgaris L., Zingiber officinale Rosc., and Panax ginseng C.A.Meyer in terms of scientifically tested antidiabetic activity and the presence of characteristic biologically active compounds and their specific properties, including antioxidant properties. The characteristics of these raw materials are based on in vitro as well as in vivo studies: on animals and in clinical studies. In addition, for each plant, the possibility to use certain morphological elements in the light of EFSA legislation is given.
Collapse
Affiliation(s)
- Monika Przeor
- Department of Gastronomy Science and Functional Foods, Poznań University of Life Sciences, 60-637 Poznań, Poland
| |
Collapse
|
6
|
Zhang X, Han L, Li P, Zhang S, Zhang M, Li X, Chu J, Wang L, Tu P, Zhang Y, Liu K. Region-Specific Biomarkers and Their Mechanisms in the Treatment of Lung Adenocarcinoma: A Study of Panax quinquefolius from Wendeng, China. Molecules 2021; 26:molecules26226829. [PMID: 34833921 PMCID: PMC8623508 DOI: 10.3390/molecules26226829] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2021] [Revised: 10/29/2021] [Accepted: 11/05/2021] [Indexed: 12/16/2022] Open
Abstract
Panax quinquefolius, a popular medicinal herb, has been cultivated in China for many years. In this work, the region-specific profiles of metabolites in P. quinquefolius from Wendeng was investigated using liquid-chromatography-quadrupole-time-of-flight-(LC-Q-TOF)-based metabolomics analysis. The three most abundant biomarkers, identified as ginsenoside Rb3, notoginsenoside R1, and ginsenoside Rc, were the representative chemical components employed in the network pharmacology analysis. In addition, molecular docking and western blotting analyses revealed that the three compounds were effective binding ligands with Hsp90α, resulting in the inactivation of SRC and PI3K kinase, which eventually led to the inactivation of the Akt and ERK pathways and lung cancer suppression. The outcomes obtained herein demonstrated the intriguing chemical characteristics and potential functional activities of P. quinquefolius from Wendeng.
Collapse
Affiliation(s)
- Xuanming Zhang
- Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China; (X.Z.); (P.L.); (S.Z.); (M.Z.); (X.L.); (J.C.); (L.W.)
| | - Liwen Han
- Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 256200, China;
| | - Peihai Li
- Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China; (X.Z.); (P.L.); (S.Z.); (M.Z.); (X.L.); (J.C.); (L.W.)
| | - Shanshan Zhang
- Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China; (X.Z.); (P.L.); (S.Z.); (M.Z.); (X.L.); (J.C.); (L.W.)
| | - Mengqi Zhang
- Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China; (X.Z.); (P.L.); (S.Z.); (M.Z.); (X.L.); (J.C.); (L.W.)
| | - Xiaobin Li
- Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China; (X.Z.); (P.L.); (S.Z.); (M.Z.); (X.L.); (J.C.); (L.W.)
| | - Jie Chu
- Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China; (X.Z.); (P.L.); (S.Z.); (M.Z.); (X.L.); (J.C.); (L.W.)
| | - Lizhen Wang
- Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China; (X.Z.); (P.L.); (S.Z.); (M.Z.); (X.L.); (J.C.); (L.W.)
| | - Pengfei Tu
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China;
| | - Yun Zhang
- Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China; (X.Z.); (P.L.); (S.Z.); (M.Z.); (X.L.); (J.C.); (L.W.)
- Correspondence: (Y.Z.); (K.L.)
| | - Kechun Liu
- Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China; (X.Z.); (P.L.); (S.Z.); (M.Z.); (X.L.); (J.C.); (L.W.)
- Correspondence: (Y.Z.); (K.L.)
| |
Collapse
|
7
|
Chandra S, Toppo A. Antioxidant and antiacetylcholinestrase studies of In vitro regenerated and transformed hairy roots of Ocimum sanctum (L.). Pharmacogn Mag 2021. [DOI: 10.4103/pm.pm_539_20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
8
|
Elateeq AA, Sun Y, Nxumalo W, Gabr AM. Biotechnological production of silymarin in Silybum marianum L.: A review. BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY 2020. [DOI: 10.1016/j.bcab.2020.101775] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|